Patients with atrial fibrillation and mid-range ejection fraction differ in anticoagulation pattern, thrombotic and mortality risk independently of CHA 2 DS 2 -VAS C score

AbstractAtrial fibrillation (AF) patients with mid-range left ventricular ejection fraction (mrEF) of 40 –49% have neither preserved (pEF >  50%) nor reduced (rEF 
Source: Heart and Vessels - Category: Cardiology Source Type: research

Related Links:

Authors: Katsiki N, Tousoulis D PMID: 32454183 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Cardiology - Category: Cardiology Tags: Hellenic J Cardiol Source Type: research
Authors: Dehghani MR, Shariati A, Haghjou A, Izadi S, Sattartabar B, Rezaei Y Abstract BACKGROUND: Several factors and risk stratification tools have been studied to determine the prognosis of acute coronary syndrome. Fragmented QRS (fQRS) is a marker of myocardial scar and its prognostic role has recently been demonstrated. The present study aimed to investigate the association between the presence of fQRS in electrocardiogram and the prognosis of ST-segment elevation and non-ST-segment elevation myocardial infarction (STEMI and NSTEMI). METHODS: A total of 661 patients with myocardial infarction (MI...
Source: Herz - Category: Cardiology Tags: Herz Source Type: research
Publication date: Available online 27 May 2020Source: Mechanisms of Ageing and DevelopmentAuthor(s): Maurizio Forte, Rosita Stanzione, Maria Cotugno, Franca Bianchi, Simona Marchitti, Speranza Rubattu
Source: Mechanisms of Ageing and Development - Category: Geriatrics Source Type: research
Publication date: Available online 27 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Souvik Dubey, Payel Biswas, Ritwik Ghosh, Subhankar Chatterjee, Mahua Jana Dubey, Subham Chatterjee, Durjoy Lahiri, Carl J. Lavie
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 27 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Channabasappa Shivaprasad, Kolla Gautham, Preethika Palani, Soumya Gupta, Kejal Shah
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: June 2020Source: Canadian Journal of Diabetes, Volume 44, Issue 4Author(s): Kelly Buxton, Lisa M. Lix, Anne Champagne, Charity Evans, Yvonne Shevchuk, Gary Teare, Kerry Mansell, David F. Blackburn
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: June 2020Source: Canadian Journal of Diabetes, Volume 44, Issue 4Author(s): Himadri Kalita, Ankita Hazarika, Rajlakshmi Devi
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: June 2020Source: Canadian Journal of Diabetes, Volume 44, Issue 4Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: June 2020Source: Canadian Journal of Diabetes, Volume 44, Issue 4Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Conclusion: Our findings describe the most reported risk factors for preventability of oral anticoagulant-induced bleedings. These factors may be useful for targeting interventions to improve pharmacovigilance activities in our regional territory and to reduce the burden of medication errors and inappropriate prescription. Introduction Oral anticoagulant therapy is widely used for the prevention of stroke and systemic embolism in patients with atrial fibrillation, or for the prevention and treatment of deep vein thrombosis and pulmonary embolism (Raj et al., 1994; Monaco et al., 2017). Oral anticoagulants can be di...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Cholesterol | Coumadin | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Hypertension | Statistics | Thrombosis | Warfarin